Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2007-06-29
2010-06-22
Huff, Sheela J (Department: 1643)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009500, C424S009600, C424S009300, C424S001490, C435S004000, C435S007210
Reexamination Certificate
active
07740830
ABSTRACT:
The present invention relates to endothelial cell-specific genes and encoded polypeptides and materials and uses thereof in the imaging, diagnosis and treatment of conditions involving the vascular endothelium.
REFERENCES:
patent: 6069007 (2000-05-01), Rossi et al.
patent: 6225118 (2001-05-01), Grant et al.
patent: 7163797 (2007-01-01), Ruben et al.
patent: 7498034 (2009-03-01), Bicknell et al.
patent: 2003/0072736 (2003-04-01), Baker et al.
patent: 2004/0071711 (2004-04-01), Bicknell et al.
patent: 2006/0099143 (2006-05-01), Bicknell et al.
patent: 2006/0263369 (2006-11-01), Bicknell et al.
patent: 2007/0025913 (2007-02-01), Bicknell et al.
patent: 2008/0019963 (2008-01-01), Bicknell et al.
patent: 2008/0145359 (2008-06-01), Bicknell et al.
patent: 2008/0166295 (2008-07-01), Bicknell et al.
patent: 0 682 113 (1995-11-01), None
patent: 1 074 617 (2000-07-01), None
patent: WO 99/06423 (1999-02-01), None
patent: WO 99/11293 (1999-03-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO 99/53051 (1999-10-01), None
patent: WO 00/53756 (2000-09-01), None
patent: WO 01/23523 (2001-04-01), None
Tockman et al, Cancer Research vol. 52 p. 2711s (1992).
Skolnick et al. (Trends in Biotech., 18(1):34-39, 2000).
Amalfitano, A and Parks, R.J. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr Gene Ther. May 2002;2(2):111-33. Review.
Bechard, D. et al., Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. Sep.-Oct. 2000;37(5):417-25.
Bortoluzzi, S. et al., The human adult skeletal muscle transcriptional profile reconstructed by a novel computational approach. Genome Res. Mar. 2000;10(3):344-9.
Brose, K. et al., Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell. Mar. 19, 1999;96(6):795-806.
Chen, H. et al., Characterization of gene expression in resting and activated mast cells. J Exp Med. Nov. 2, 1998;188(9):1657-68. Erratum in: J Exp Med Dec. 21, 1998;188(12):2387.
Clark, D.E. et al., Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod. May 1996;11(5):1090-8.
Cole, K.A. et al., The genetics of cancer—a 3D model. Nat Genet. Jan. 1999;21(1 Suppl):38-41. Review.
Compton, J., Nucleic acid sequence-based amplification. Nature. Mar. 7, 1991;350(6313):91-2.
Cserzö, M. et al., Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Eng. Jun. 1997;10(6):673-6.
Cwirla, S.E. et al., Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A. Aug. 1990;87(16):6378-82.
Dillon, N. and Sabbattini, P. Functional gene expression domains: defining the functional unit of eukaryotic gene regulation. Bioessays. Jul. 2000;22(7):657-65. Review.
Dorai, T. et al., Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents. Anticancer Res. Sep.-Oct. 1997;17(5A):3307-12.
Felbor, U. et al., Genomic organization and chromosomal localization of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene: a candidate for 6q-linked retinopathies. Cytogenet Cell Genet. 1998;81(1):12-7.
Fong, G.H. et al., Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. Jul. 6, 1995;376(6535):66-70.
Gerhold, D. and Caskey, C.T. It's the genes! EST access to human genome content. Bioessays. Dec. 1996;18(12):973-81. Review.
Ginsburg, D. et al., Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science. Jun. 21, 1985;228(4706):1401-6.
Hayward, C.P. et al., An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood. Jun. 15, 1996;87(12):4967-78.
Hayward, C.P. et al; Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest. Jun. 1993;91(6):2630-9.
Hayward, C.P. et al., Studies of multimerin in human endothelial cells. Blood. Feb. 15, 1998;91(4):1304-17.
von Heijne, G., Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol. May 20, 1992;225(2):487-94.
Höckel, M. and Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. Feb. 21, 2001;93(4):266-76. Review.
Huminiecki, L. et al., Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics. Apr. 2002;79(4):547-52.
Huminiecki, L., In Silico cloning of novel endothelial specific genes: Their role in Angiogenesis. Angiogenesis. 2001; 7:220-221.
Huminiecki, L. and Bicknell, R. In silico cloning of novel endothelial-specific genes. Genome Res. Nov. 2000;10(11):1796-806.
Itoh, K. et al., Expression profile of active genes in granulocytes. Blood. Aug. 15, 1998;92(4):1432-41.
Kidd, T. et al., Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell. Jan. 23, 1998;92(2):205-15.
Lassalle, P. et al., ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. Aug. 23, 1996;271(34):20458-64.
Li, H.S. et al., Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell. Mar. 19, 1999;96(6):807-18.
Matthews, W. et al., A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A. Oct. 15, 1991;88(20):9026-30.
Maxwell, P.H. et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. May 20, 1999;399(6733):271-5.
Nichols, W.L. et al., Identification of human megakaryocyte coagulation factor V. Blood. Jun. 1985;65(6):1396-406.
Nielsen, H. et al., Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. Jan. 1997;10(1):1-6.
Obermair, A. et al., Vascular endothelial growth factor and its receptors in male fertility. Fertil Steril. Aug. 1999;72(2):269-75.
Partanen, J. et al., A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol. Apr. 1992;12(4):1698-707.
Petrenko, O. et al., The molecular characterization of the fetal stem cell marker AA4. Immunity. Jun. 1999;10(6):691-700.
Sato, T.N. et al., Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A. Oct. 15, 1993;90(20):9355-8. Erratum in: Proc Natl Acad Sci U S A Dec. 15, 1993;90(24):12056.
Sato, T.N. et al., Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. Jul. 6, 1995;376(6535):70-4.
Schuler, G.D., Pieces of the puzzle: expressed sequence tags and the catalog of human genes. J Mol Med. Oct. 1997;75(10):694-8. Review.
Shalaby, F. et al., Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. Jul. 6, 1995;376(6535):62-6.
Shibuya, M. et al., Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. Apr. 1990;5(4):519-24.
Skolnick, J. and Fetrow, J.S. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends Biotechnol. Jan. 2000;18(1):34-9. Review.
Soker, S. et al., Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. Mar. 20, 1998;92(6):735-45.
Sporn, L.A. et al., Biosynthesi
Bicknell Roy
Huminiecki Lukasz
Cancer Research Technology Limited
Huff Sheela J
Wolf Greenfield & Sacks P.C.
LandOfFree
Imaging, diagnosis and treatment of disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imaging, diagnosis and treatment of disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging, diagnosis and treatment of disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185217